Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1B Single Treatment, Pharmacokinetic and Tolerance Study of NatroVA Topical Creme (1%) i Pediatric Subjects 6 to 24 Months of Age

NCT00410709 is registered in ClinicalTrials.gov with ParaPRO LLC as lead sponsor.

NCT NCT00410709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00410709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1B Single Treatment, Pharmacokinetic and Tolerance Study of NatroVA Topical Creme (1%) i Pediatric Subjects 6 to 24 Months of Age
Lead sponsor
ParaPRO LLC
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2006
Completion date
January 31, 2007
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pediculosis capitis (head lice)